Key result
Symptom relief after AF cardioversion correlates with increased cardiac output and decreased RR variability.
Why the study?
Symptoms in AF range from none to disabling, but the physiological correlates of AF symptoms are not well characterized.
Does electrical cardioversion improve symptoms and quality of life in correlation with physiological parameters in patients with persistent atrial fibrillation?
Observational (n=44)
Does electrical cardioversion improve symptoms and quality of life in correlation with physiological parameters in patients with persistent atrial fibrillation?
Effect estimate: r = 0.36
p-value: p=<0.05
Improvements in symptoms and quality of life after electrical cardioversion of atrial fibrillation correlate with increased cardiac output and decreased RR variability.
These associations should not yet change cardioversion practice in persistent AF; hypothesis-generating and require randomized confirmation.
Objectives Symptoms in atrial fibrillation (AF) range from none to disabling. The physiological correlates of AF symptoms are not well characterized. This study investigated the association between physiological parameters and symptom severity before and after electrical cardioversion (EC) of AF.Design We studied 44 patients with persistent AF (age 66.2 ± 7.9 years, 16% females) 4 ± 2 days before and 5 ± 2 days after EC. Physiological parameters included cardiac output (CO; non-invasive inert gas rebreathing), heart rate (HR), RR variability and resting and ambulatory blood pressure (BP). Symptoms and quality of life (QoL) were assessed by the modified European Heart Rhythm Association score (mEHRA), the Atrial Fibrillation Effect on Quality of Life (AFEQT) and the Symptom Checklist for frequency and severity of symptoms (SCL).Results 28 of 44 patients were still in sinus rhythm (SR) at post EC evaluation. Those in SR had a decreased HR (-15.4 ± 13.1 bpm, p < 0.001), and an increased CO (+0.8 ± 0.7 L/min, p < 0.001) as compared to those with recurrent AF. Changes in CO after EC correlated with symptom improvement as scored by AFEQT (r = 0.36; p < 0.05), AFEQT symptoms subscore (r = 0.46; p < 0.01), SCL for frequency (r = 0.62; p < 0.01) and severity (r = 0.33; p < 0.05) of symptoms, and the mEHRA score (r = 0.50; p < 0.01). A decrease in RR variability showed similar correlations with these measures of symptom improvement.Conclusions Improvements in symptoms and quality of life experienced by patients after electrical conversion of atrial fibrillation are correlated with an increase in CO and a decreased RR variability.
No takes yet. Share an insight, caveat, or question.
Klavebäck et al. (2023) conducted an observational in persistent atrial fibrillation (n=44). Electrical cardioversion vs. Recurrent atrial fibrillation was evaluated on Correlation between changes in cardiac output after electrical cardioversion and symptom improvement (AFEQT) (r = 0.36, p=<0.05). Improvements in symptoms and quality of life after electrical cardioversion of atrial fibrillation correlated with increased cardiac output (r=0.36, p<0.05 for AFEQT) and decreased RR variability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: